GL1X · GenesisL1 explorer

MolNFT v1 · #98957 · protein

Crystal structure of the human rage VC1 fragment in space group P62

4LP4 · Advanced glycosylation end product-specific receptor: “Crystal structure of the human rage VC1 fragment in space group P62”. X-ray diffraction, 1 ligand (NA), 7 pockets (best druggability 0.45). MolNFT v1 #98957 on GenesisL1: 3D…

PDB
4LP4
Type
protein
Length
424 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Advanced glycosylation end product-specific receptor
UniProt
Q15109
Ligands
NA
Pockets
7 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BAdvanced glycosylation end product-specific receptorprotein2123% helix, 48% strandQ15109

Ligands and binding sites

  • NA · Sodium ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11040.450.7819empty
21020.430.7819empty
31380.400.7423empty
41510.390.7325empty
5860.320.7317empty

Interfaces

1 interface between chains.

  • A–B · 572 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4LP4 · Crystal structure of the human RAGE VC1 fragment in space group P62 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.